Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. The ABOGRAFT Trial

NCT05169229 is registered in ClinicalTrials.gov with University Hospital, Linkoeping as lead sponsor.

NCT NCT05169229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05169229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. The ABOGRAFT Trial
Lead sponsor
University Hospital, Linkoeping
Phase
Phase 2
Overall status
Recruiting
Start date
April 1, 2022
Completion date
December 31, 2031
Enrollment
1,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, arthroplasty, replacement, hip, osteoarthritis, hip, prosthetic joint infection